Benjamin Miron
Impact in
-
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
- Surgery 13
- Bladder and Urothelial Cancer Treatments 10
- Urinary and Genital Oncology Studies 7
- Esophageal Cancer Research and Treatment 3
-
- Lung Cancer Treatments and Mutations 5
- Renal cell carcinoma treatment 4
- Co-authors
- Matthew R. Zibelman (12 shared papers)David P. Kelsen (2 shared papers)David H. Ilson (3 shared papers)Douglas A. Levine (1 shared paper)Jeff Boyd (1 shared paper)David S. Klimstra (1 shared paper)Marinela Capanu (1 shared paper)Gary K. Schwartz (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)European Urology Oncology (2 papers)Cancer (1 paper)Molecular Oncology (1 paper)Journal of Personalized Medicine (1 paper)
- Partner nations
- United StatesIsraelFrance
In The Last Decade
Benjamin Miron
19 papers receiving 275 citations
Peers
Comparison fields: 5 of 34
- Pulmonary and Respiratory Medicine 160
- Oncology 130
- Urology 19
- Surgery 131
- Cancer Research 43
Countries citing papers authored by Benjamin Miron
This map shows the geographic impact of Benjamin Miron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Miron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Miron more than expected).
Fields of papers citing papers by Benjamin Miron
This network shows the impact of papers produced by Benjamin Miron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Miron. The network helps show where Benjamin Miron may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Miron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 69 | |
| 2 | 2020 | 54 | |
| 3 | 2017 | 40 | |
| 4 | 2023 | 29 | |
| 5 | 2023 | 18 | |
| 6 | 2022 | 17 | |
| 7 | 2008 | 11 | |
| 8 | 2009 | 8 | |
| 9 | 2020 | 6 | |
| 10 | 2023 | 5 | |
| 11 | 2024 | 5 | |
| 12 | 2021 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2022 | 2 | |
| 15 | 2019 | 2 | |
| 16 | 2019 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2016 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2023 | 0 |
About Benjamin Miron
Benjamin Miron is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Molecular Biology, having authored 23 papers that have together received 277 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (10 papers), Urinary and Genital Oncology Studies (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers), Renal cell carcinoma treatment (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (160 citations), Oncology (130 citations), Urology (19 citations), Surgery (131 citations) and Cancer Research (43 citations). Benjamin Miron has collaborated with scholars based in United States, Israel and France. Frequent co-authors include Matthew R. Zibelman, David P. Kelsen, David H. Ilson, Douglas A. Levine, Jeff Boyd, David S. Klimstra, Marinela Capanu, Gary K. Schwartz, Manish A. Shah and Elizabeth R. Plimack. Their work appears in journals such as Journal of Clinical Oncology, European Urology Oncology, Cancer, Molecular Oncology and Journal of Personalized Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.